Pharmaceutical composition for immunomodulating and adjuvant...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/70 (2006.01) A61K 9/08 (2006.01) A61K 31/19 (2006.01) A61K 31/195 (2006.01) A61K 31/34 (2006.01) A61K 31/375 (2006.01) A61K 31/44 (2006.01) A61K 31/455 (2006.01) A61K 31/51 (2006.01) A61K 31/715 (2006.01) C07H 3/08 (2006.01)

Patent

CA 2166774

Pharmaceutical composition for immunomodulating and adjuvant therapy containing a metabolic stressor, 2-deoxy-D-ribose and further active components, i.e. ribose, DL-alanine, nicotonic acid, L-ascorbic acid, thiamin and glutamic acid amide is intended for immunomodulating and adjuvant therapy and for prevention of weakening of the immunity system. .ang.

Cette composition pharmaceutique pour thérapie immunorégulatrice et auxiliaire contient un agent d'agression du métabolisme, du 2-désoxy-D-ribose et d'autres composants actifs, à savoir, le ribose, la DL-alanine, l'acide nicotinique, l'acide L-ascorbique, la thiamine et un amide de l'acide glutaminique. Cette composition est destinée à une thérapie immunorégulatrice et auxiliaire et à la prévention de l'affaiblissement du système immunitaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition for immunomodulating and adjuvant... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for immunomodulating and adjuvant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for immunomodulating and adjuvant... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1756445

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.